WO2003102541A3 - Universal biosensor and methods of use - Google Patents

Universal biosensor and methods of use Download PDF

Info

Publication number
WO2003102541A3
WO2003102541A3 PCT/US2003/017115 US0317115W WO03102541A3 WO 2003102541 A3 WO2003102541 A3 WO 2003102541A3 US 0317115 W US0317115 W US 0317115W WO 03102541 A3 WO03102541 A3 WO 03102541A3
Authority
WO
WIPO (PCT)
Prior art keywords
analyte
marker
methods
binding material
test sample
Prior art date
Application number
PCT/US2003/017115
Other languages
French (fr)
Other versions
WO2003102541A2 (en
Inventor
Antje J Baeumner
Original Assignee
Cornell Res Foundation Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cornell Res Foundation Inc filed Critical Cornell Res Foundation Inc
Priority to EP03756301A priority Critical patent/EP1512010B1/en
Priority to AU2003243348A priority patent/AU2003243348B2/en
Priority to CA002485942A priority patent/CA2485942A1/en
Priority to DE60318435T priority patent/DE60318435T2/en
Publication of WO2003102541A2 publication Critical patent/WO2003102541A2/en
Publication of WO2003102541A3 publication Critical patent/WO2003102541A3/en

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G01N33/54373—Apparatus specially adapted for solid-phase testing involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings
    • G01N33/5438—Electrodes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y10/00—Nanotechnology for information processing, storage or transmission, e.g. quantum computing or single electron logic
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form

Abstract

The present invention relates to methods for detecting or quantifying an analyte in a test sample including providing at least one test mixture including a test sample, at least one marker complex, wherein each marker complex includes a particle, a marker, and one member of a coupling group, a first binding material selected to bind to a portion of the analyte, a second binding material selected to bind with a portion of the analyte other than the portion of the analyte for which the first binding material is selected, analyte analog, and/or marker conjugate. The at least one test mixture is passed through a membrane. The amount of marker on the membrane is detected and correlated to the presence or amount of analyte in the test sample.
PCT/US2003/017115 2002-05-31 2003-05-30 Universal biosensor and methods of use WO2003102541A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
EP03756301A EP1512010B1 (en) 2002-05-31 2003-05-30 Universal biosensor and methods of use
AU2003243348A AU2003243348B2 (en) 2002-05-31 2003-05-30 Universal biosensor and methods of use
CA002485942A CA2485942A1 (en) 2002-05-31 2003-05-30 Universal biosensor and methods of use
DE60318435T DE60318435T2 (en) 2002-05-31 2003-05-30 UNIVERSAL BIOSENSOR AND METHOD OF USE

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38514602P 2002-05-31 2002-05-31
US60/385,146 2002-05-31

Publications (2)

Publication Number Publication Date
WO2003102541A2 WO2003102541A2 (en) 2003-12-11
WO2003102541A3 true WO2003102541A3 (en) 2004-02-19

Family

ID=29712137

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/017115 WO2003102541A2 (en) 2002-05-31 2003-05-30 Universal biosensor and methods of use

Country Status (7)

Country Link
US (1) US7718388B2 (en)
EP (2) EP1939627B1 (en)
AT (2) ATE382861T1 (en)
AU (1) AU2003243348B2 (en)
CA (1) CA2485942A1 (en)
DE (2) DE60318435T2 (en)
WO (1) WO2003102541A2 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005084404A2 (en) * 2004-03-03 2005-09-15 Cornell Research Foundation, Inc. Microfluidic biosensor and methods of use
DE102005037436A1 (en) * 2005-08-04 2007-02-15 Siemens Ag Method and system for determining the concentration of an analyte-enzyme complex or analyte-enzyme conjugate, in particular for the electrochemical detection of the analyte, and associated measuring device
WO2010058059A1 (en) * 2008-11-18 2010-05-27 University Of Jyväskylä A method for detecting specific nucleotide sequences
JP2011047923A (en) * 2009-07-27 2011-03-10 Panasonic Corp Liposome composition, method for producing the same, and method for analyzing analyte by using the same
US8956859B1 (en) 2010-08-13 2015-02-17 Aviex Technologies Llc Compositions and methods for determining successful immunization by one or more vaccines
WO2012081940A2 (en) * 2010-12-16 2012-06-21 한국생명공학연구원 Membrane phase electrode using printing and bio-molecule detection using same
KR101335246B1 (en) * 2010-12-16 2013-11-29 한국생명공학연구원 An Electrode on a Membrane by Printing and Its Application to the Detection of Biomaterials
WO2013074796A1 (en) 2011-11-15 2013-05-23 The Board Of Trustees Of The University Of Illinois Thermal control of droplets by nanoscale field effect transistors
CN102680705A (en) * 2012-05-15 2012-09-19 南昌大学 Method for quantitatively detecting allergen alpha-lactalbumin based on quantum dot fluorescence
EP2986987B1 (en) 2013-04-15 2018-08-08 Nanyang Technological University Electrochemical lateral flow bioassay and biosensor
CN105675678B (en) * 2016-02-29 2018-01-05 北京农业质量标准与检测技术研究中心 Monoethanolamine detection method based on the fit DNA biosensor of electrochemistry
WO2020003087A1 (en) * 2018-06-26 2020-01-02 Tdk Corporation Kit and method for detecting dna
CN110531074B (en) * 2019-09-06 2022-07-05 齐鲁工业大学 Method for detecting campylobacter jejuni
GB2604367A (en) * 2021-03-03 2022-09-07 Biotip Ltd Devices and methods for performing lateral flow tests

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5498551A (en) * 1985-12-23 1996-03-12 Janssen Pharmaceutica N.V. Method for the detection of specific binding agents and their corresponding bindable substances
US5529902A (en) * 1993-10-26 1996-06-25 Mayo Foundation For Medical Education And Research Direct fluorescence-conjugated immunoassay for platelet activation
US5863538A (en) * 1992-03-05 1999-01-26 Board Of Regents, The University Of Texas System Compositions for targeting the vasculature of solid tumors
US5948624A (en) * 1994-05-11 1999-09-07 Rothschild; Kenneth J. Methods for the detection and isolation of biomolecules
US20020102581A1 (en) * 1999-02-19 2002-08-01 Hageman Gregory S. Diagnostics and therapeutics for ocular disorders
US6576460B1 (en) * 1999-10-28 2003-06-10 Cornell Research Foundation, Inc. Filtration-detection device and method of use
US20030162198A1 (en) * 1994-05-11 2003-08-28 The Trustees Of Boston University Diagnosing genetic disorders

Family Cites Families (95)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4048298A (en) 1975-02-25 1977-09-13 Rohm And Haas Company Solid phase double-antibody radioimmunoassay procedure
US4172770A (en) 1978-03-27 1979-10-30 Technicon Instruments Corporation Flow-through electrochemical system analytical method
US4225410A (en) 1978-12-04 1980-09-30 Technicon Instruments Corporation Integrated array of electrochemical sensors
US4235601A (en) 1979-01-12 1980-11-25 Thyroid Diagnostics, Inc. Test device and method for its use
IE50457B1 (en) 1979-01-18 1986-04-30 Unilever Ltd Method for detecting and determining proteinaceous specific binding agents and materials bindable thereto,test composition and test kit therefor
US4342826A (en) 1980-02-04 1982-08-03 Collaborative Research, Inc. Immunoassay products and methods
US4668619A (en) 1980-10-30 1987-05-26 Miles Laboratories, Inc. Multilayer homogeneous specific binding assay device
US4517288A (en) 1981-01-23 1985-05-14 American Hospital Supply Corp. Solid phase system for ligand assay
US4517303A (en) 1982-10-20 1985-05-14 E. I. Du Pont De Nemours And Company Specific binding assays utilizing analyte-cytolysin conjugates
US4571543A (en) 1983-03-28 1986-02-18 Southwest Medical Products, Inc. Specific material detection and measuring device
US4636479A (en) 1983-04-20 1987-01-13 Cooper-Lipotech, Inc. Enhanced agglutination method and kit
US4605630A (en) 1983-07-27 1986-08-12 Cooper Lipotech Inc. Large-liposome agglutination reagent and method
US4594327A (en) 1983-11-02 1986-06-10 Syntex (U.S.A.) Inc. Assay method for whole blood samples
US4695554A (en) 1984-02-14 1987-09-22 Becton Dickinson And Company Sac or liposome containing dye (sulforhodamine) for immunoassay
US4703017C1 (en) 1984-02-14 2001-12-04 Becton Dickinson Co Solid phase assay with visual readout
US4708933A (en) 1984-06-12 1987-11-24 Leaf Huang Immunoliposome assay-methods and products
US5141868A (en) 1984-06-13 1992-08-25 Internationale Octrooi Maatschappij "Octropa" Bv Device for use in chemical test procedures
US4880635B1 (en) 1984-08-08 1996-07-02 Liposome Company Dehydrated liposomes
JPH076984B2 (en) 1985-05-31 1995-01-30 株式会社日立製作所 Multiple item analysis method
US5047245A (en) 1985-07-26 1991-09-10 The Liposome Company, Inc. Novel composition for targeting, storing and loading of liposomes
US4806311A (en) 1985-08-28 1989-02-21 Miles Inc. Multizone analytical element having labeled reagent concentration zone
US4752572A (en) 1985-08-30 1988-06-21 Eastman Kodak Company Lipid vesicles containing labeled species and their analytical uses
JPH0650315B2 (en) 1985-11-08 1994-06-29 株式会社日立製作所 Immunological analysis reagent and immunological analysis method
US4822566A (en) 1985-11-19 1989-04-18 The Johns Hopkins University Optimized capacitive sensor for chemical analysis and measurement
US5501949A (en) * 1985-12-10 1996-03-26 Murex Diagnostics Corporation Particle bound binding component immunoassay
US4874710A (en) 1986-02-20 1989-10-17 Becton Dickinson And Company Assay and product in which binder and liposomes are supported on a solid support
US5039818A (en) 1986-02-27 1991-08-13 Syntex (U.S.A.) Inc. Squaraine dye
US4960692A (en) * 1986-03-18 1990-10-02 Fisher Scientific Company Assay employing binding pair members on particles and on a filter or membrane
US5137827A (en) * 1986-03-25 1992-08-11 Midwest Research Technologies, Inc. Diagnostic element for electrical detection of a binding reaction
US5085987A (en) 1986-09-05 1992-02-04 Syntex (U.S.A.) Inc. Immunoseparating strip
US5310650A (en) 1986-09-29 1994-05-10 Abbott Laboratoires Method and device for improved reaction kinetics in nucleic acid hybridizations
US5169789A (en) 1986-12-03 1992-12-08 New Horizons Diagnostics Corporation Device and method for self contained solid phase immunodiffusion assay
GB2200448B (en) 1987-01-23 1991-01-16 Univ London Targetted liposomes and their use in immunoassay
US4920046A (en) 1987-02-20 1990-04-24 Becton, Dickinson And Company Process, test device, and test kit for a rapid assay having a visible readout
US5089181A (en) 1987-02-24 1992-02-18 Vestar, Inc. Method of dehydrating vesicle preparations for long term storage
CA1303983C (en) 1987-03-27 1992-06-23 Robert W. Rosenstein Solid phase assay
ES2050704T5 (en) 1987-04-27 2004-04-16 Inverness Medical Switzerland Gmbh IMMUNOENSAYS AND DEVICES FOR THEIR REALIZATION.
EP0313666B1 (en) 1987-05-06 1993-04-21 Teijin Limited Method for immunoassay utilizing liposome and kit therefor
US4855240A (en) 1987-05-13 1989-08-08 Becton Dickinson And Company Solid phase assay employing capillary flow
US5001048A (en) 1987-06-05 1991-03-19 Aurthur D. Little, Inc. Electrical biosensor containing a biological receptor immobilized and stabilized in a protein film
IT1223295B (en) 1987-08-14 1990-09-19 Boehringer Biochemia Srl IMMUNODIAGNOSTIC DEVICE AND METHOD
US5459041A (en) 1988-02-18 1995-10-17 Enteric Research Laboratories, Inc. Campylobacter pylori antigens and uses thereof for detection of Campylobacter pylori infection
US5389523A (en) 1988-05-31 1995-02-14 The United States Of Americas, As Represented By The Secretary Of Commerce Liposome immunoanalysis by flow injection assay
US5141751A (en) 1988-06-29 1992-08-25 Daiichi Pharmaceutical Co., Ltd. Lipid membrane structures
US5006473A (en) 1988-08-09 1991-04-09 Abbott Laboratories Electrophoresis method using vesicles
US5096629A (en) 1988-08-29 1992-03-17 501 Nippon Fine Chemical Co., Ltd. Method for preparing lipid powder for use in preparing liposomes and method for preparing liposomes
US5130257A (en) 1988-09-29 1992-07-14 Hewlett-Packard Company Chemical sensor utilizing a surface transverse wave device
EP0437479B1 (en) 1988-10-05 1994-06-22 Vestar, Inc. Method of making liposomes with improved stability during drying
US5200051A (en) 1988-11-14 1993-04-06 I-Stat Corporation Wholly microfabricated biosensors and process for the manufacture and use thereof
US5208143A (en) 1988-11-17 1993-05-04 Becton, Dickinson And Company Immunoassay on a preblocked solid surface
US5312762A (en) 1989-03-13 1994-05-17 Guiseppi Elie Anthony Method of measuring an analyte by measuring electrical resistance of a polymer film reacting with the analyte
EP0387696B1 (en) 1989-03-17 1997-08-27 Abbott Laboratories Method and device for improved reaction kinetics in nucleic acid hybridizations
JPH02308800A (en) 1989-05-24 1990-12-21 Toshiba Corp Gene diagnosis method
US5198367A (en) 1989-06-09 1993-03-30 Masuo Aizawa Homogeneous amperometric immunoassay
US5156810A (en) 1989-06-15 1992-10-20 Biocircuits Corporation Biosensors employing electrical, optical and mechanical signals
US5491097A (en) 1989-06-15 1996-02-13 Biocircuits Corporation Analyte detection with multilayered bioelectronic conductivity sensors
US5045285A (en) 1989-09-05 1991-09-03 United States Of America As Represented By The Secretary Of The Air Force Gaseous component identification with polymeric film sensor
US5305757A (en) 1989-12-22 1994-04-26 Unger Evan C Gas filled liposomes and their use as ultrasonic contrast agents
EP0437092A1 (en) 1989-12-25 1991-07-17 Kabushiki Kaisha Toshiba Gene diagnosis
GB2244135B (en) 1990-05-04 1994-07-13 Gen Electric Co Plc Sensor devices
DE69229334T2 (en) 1991-01-11 1999-12-16 Quidel Corp ONE-STAGE CROSS-FLOW ANALYZING METHOD AND A NON-SUCTIONABLE CARRIER USED IN IT
US5155022A (en) 1991-02-08 1992-10-13 Becton, Dickinson And Company Assay for lyme disease
US5340716A (en) 1991-06-20 1994-08-23 Snytex (U.S.A.) Inc. Assay method utilizing photoactivated chemiluminescent label
US5567591A (en) 1991-06-24 1996-10-22 Becton Dickinson And Company Amplified assay for analyte
US5248590A (en) 1991-07-22 1993-09-28 Becton, Dickinson And Company Surface modified liposomes
WO1993010226A1 (en) 1991-11-19 1993-05-27 North Carolina State University Immunodiagnostic assay using liposomes carrying labels thereof on outer liposome surface
US5670328A (en) 1992-06-09 1997-09-23 Yamasa Corporation Monoclonal antibodies to human pulmonary surfactant apoprotein D and use thereof
US5399500A (en) 1992-06-26 1995-03-21 Becton Dickinson And Company Two step process for coating of antibodies to a solid phase
US5369036A (en) 1992-07-02 1994-11-29 Becton, Dickinson And Company Enhancement of signal in immunoassays using microparticles which contain different detectable substances
CA2140661A1 (en) 1992-07-20 1994-02-03 Sharat Singh Novel chemiluminescent compounds and methods of use
US5354692A (en) 1992-09-08 1994-10-11 Pacific Biotech, Inc. Analyte detection device including a hydrophobic barrier for improved fluid flow
AU670108B2 (en) 1992-09-11 1996-07-04 Becton Dickinson & Company Improved antibodies to plasmodium falciparum
US5308775A (en) 1992-09-15 1994-05-03 Abbott Laboratories Assay devices for concurrently detecting an analyte and confirming the test result
US5384264A (en) 1992-11-05 1995-01-24 Syntron Bioresearch, Inc. Method and apparatus for single step assays of ligand-containing fluids
IL107628A0 (en) 1992-11-18 1994-02-27 Calypte Inc Immunoassays for microorganisms associated with sexually transmitted diseases
FI92882C (en) 1992-12-29 1995-01-10 Medix Biochemica Ab Oy Disposable test strip and process for its manufacture
US5393527A (en) 1993-01-04 1995-02-28 Becton, Dickinson And Company Stabilized microspheres and methods of preparation
US5532133A (en) 1993-06-02 1996-07-02 New York University Plasmodium vivax blood stage antigens, PvESP-1, antibodies, and diagnostic assays
US6103127A (en) 1993-06-08 2000-08-15 Cortex Biochem, Inc. Methods for removing hazardous organic molecules from liquid waste
JP3267000B2 (en) 1993-09-13 2002-03-18 株式会社ニコン Aspherical mirror manufacturing method
US5789154A (en) 1993-10-12 1998-08-04 Cornell Research Foundation, Inc. Liposome-enhanced immunoassay and test device
US5756362A (en) 1993-10-12 1998-05-26 Cornell Research Foundation, Inc. Liposome-enhanced immunoaggregation assay and test device
DE4437274C2 (en) 1994-10-18 1998-11-05 Inst Chemo Biosensorik Analyte selective sensor
US5780010A (en) 1995-06-08 1998-07-14 Barnes-Jewish Hospital Method of MRI using avidin-biotin conjugated emulsions as a site specific binding system
US5738868A (en) 1995-07-18 1998-04-14 Lipogenics Ltd. Liposome compositions and kits therefor
US5776487A (en) 1996-04-19 1998-07-07 Pasteur Sanofi Diagnostics Liposome reagents for immunoassays
US5756879A (en) 1996-07-25 1998-05-26 Hughes Electronics Volatile organic compound sensors
US5958791A (en) 1996-09-27 1999-09-28 Innovative Biotechnologies, Inc. Interdigitated electrode arrays for liposome-enhanced immunoassay and test device
US6358752B1 (en) 1996-09-27 2002-03-19 Cornell Research Foundation, Inc. Liposome-enhanced test device and method
US6040195A (en) 1997-06-10 2000-03-21 Home Diagnostics, Inc. Diagnostic sanitary test strip
ATE333646T1 (en) * 1998-05-21 2006-08-15 Cornell Res Foundation Inc TEST DEVICE AND METHOD IMPROVED USING LIPOSOMES
US6153411A (en) 1998-10-30 2000-11-28 American Water Works Company, Inc. Methods and kits for detection of Cryptosporidium parvum using immunomagnetic separation and amplification
CA2375532A1 (en) 1999-06-23 2000-12-28 Cornell Research Foundation, Inc. Dehydration/rehydration of marked liposomes on a test device
US6483705B2 (en) * 2001-03-19 2002-11-19 Harris Corporation Electronic module including a cooling substrate and related methods
WO2005084404A2 (en) * 2004-03-03 2005-09-15 Cornell Research Foundation, Inc. Microfluidic biosensor and methods of use

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5498551A (en) * 1985-12-23 1996-03-12 Janssen Pharmaceutica N.V. Method for the detection of specific binding agents and their corresponding bindable substances
US5863538A (en) * 1992-03-05 1999-01-26 Board Of Regents, The University Of Texas System Compositions for targeting the vasculature of solid tumors
US6261535B1 (en) * 1992-03-05 2001-07-17 The University Of Texas System Board Of Regents Diagnostic methods for targeting the vasculature of solid tumors
US5529902A (en) * 1993-10-26 1996-06-25 Mayo Foundation For Medical Education And Research Direct fluorescence-conjugated immunoassay for platelet activation
US5948624A (en) * 1994-05-11 1999-09-07 Rothschild; Kenneth J. Methods for the detection and isolation of biomolecules
US20030162198A1 (en) * 1994-05-11 2003-08-28 The Trustees Of Boston University Diagnosing genetic disorders
US20020102581A1 (en) * 1999-02-19 2002-08-01 Hageman Gregory S. Diagnostics and therapeutics for ocular disorders
US6576460B1 (en) * 1999-10-28 2003-06-10 Cornell Research Foundation, Inc. Filtration-detection device and method of use

Also Published As

Publication number Publication date
CA2485942A1 (en) 2003-12-11
EP1512010A2 (en) 2005-03-09
DE60333876D1 (en) 2010-09-30
WO2003102541A2 (en) 2003-12-11
EP1512010A4 (en) 2006-04-26
EP1939627A1 (en) 2008-07-02
AU2003243348B2 (en) 2009-12-03
DE60318435T2 (en) 2008-12-24
EP1939627B1 (en) 2010-08-18
US7718388B2 (en) 2010-05-18
DE60318435D1 (en) 2008-02-14
AU2003243348A1 (en) 2003-12-19
ATE478337T1 (en) 2010-09-15
US20100068696A1 (en) 2010-03-18
EP1512010B1 (en) 2008-01-02
ATE382861T1 (en) 2008-01-15

Similar Documents

Publication Publication Date Title
WO2003102541A3 (en) Universal biosensor and methods of use
WO2005113817A3 (en) Aptamer-nanoparticle conjugates and method of use for target analyte detection
WO2006026020A3 (en) Oncofetal fibronectin as a marker for disease and other conditions and methods for detection of oncofetal fibronectin
WO2001063284A3 (en) Internal standards and controls for multiplexed assay
WO2002083918A3 (en) Novel microarrays and methods of use thereof
WO2003023057A3 (en) Method and diagnosis kit for selecting and or qualitative and/or quantitative detection of cells
EP1019724A4 (en) Diagnostic tests and kits for clostridium difficile
WO2006126008A3 (en) Improved immunoassay methods
WO2005003732A3 (en) Diagnostic test for analytes in a sample
CA2566040A1 (en) Method for increasing the dynamic measuring range of test elements, especially immunological test elements, that are based on specific binding reactions
WO2003043487A3 (en) Method of using a non-antibody protein to detect and measure an analyte
WO2006026601A3 (en) Homogeneous enzyme immunoassay for oral fluid
WO2004000884A3 (en) Compositions and methods for apo-b48 and apo-b100 assay
WO2007001737A3 (en) Methods and compositions for detecting herpes simplex virus type 2
WO2001042788A3 (en) Analyte assay device with preabsorbing zone
WO2003058242A3 (en) Internal calibration system for flow-through assays
WO2005079420A3 (en) Chromatographic exclusion agglutination assay and methods of use thereof
WO2003106649A3 (en) Assay conjugate and uses thereof
WO2001021826A3 (en) Detecting the presence of the pyruvate kinase isoenzyme in feces
DE602004015953D1 (en) SOLID PHASE IMMUNOCHROMATOGRAPHIC TEST PROCEDURE
WO2002059600A3 (en) Analyte detection
WO2004027028A3 (en) Compositions, methods and kits for detection of an antigen on a cell and in a biological mixture
WO2004039963A8 (en) Antibodies specific for phosphorylated insulin receptor substrate-1/2 (ser 1101/ser1149) and uses thereof
WO2002050543A3 (en) Free analyte detection system
EP2444812A3 (en) Improved immunoassay methods

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2485942

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2003243348

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2003756301

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2003756301

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP

WWG Wipo information: grant in national office

Ref document number: 2003756301

Country of ref document: EP